Multiple regression analysis with disease activity score (DAS28) at 5 years of treatment as dependent outcome
Item | B | 95% CI | Standardised β | p value | R2 |
---|---|---|---|---|---|
Intercept | 1.709 | 0.517 to 2.901 | 0.005 | ||
Age | 0.006 | −0.007 to 0.018 | 0.066 | 0.384 | 0.001 |
Gender | 0.347 | −0.031 to 0.725 | 0.139 | 0.071 | 0.017 |
Treatment strategy | 0.174 | −0.172 to 0.519 | 0.076 | 0.323 | 0.017 |
Rheumatoid factor positive | 0.283 | −0.083 to 0.649 | 0.113 | 0.128 | 0.036 |
Baseline disease activity | 0.042 | −0.126 to 0.211 | 0.039 | 0.622 | 0.038 |
EULAR good-response* | −0.752 | −1.221 to −0.284 | −0.313 | 0.002 | |
EULAR moderate-response* | −0.427 | −0.877 to 0.023 | −0.184 | 0.063 | 0.091 |
↵* Early EULAR non-response used as reference category. Age, gender and treatment strategy were used as covariates. R2 = explained variance. The R2 is shown for every extra variable included in the model.